Perifosine Completed Phase 2 Trials for Central Nervous System / Brain Cancer / Cancer / Malignant Glioma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00590954Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas